National HealthCare (NHC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
3 Jul, 2026Executive summary
Net operating revenues for Q3 2024 increased 17.9% year-over-year, driven by higher per diem rates and the White Oak Senior Living acquisition.
GAAP net income attributable to stockholders was $42.8M for Q3 2024, up from $10.4M in Q3 2023; adjusted net income was $19.9M, up from $13.3M.
The White Oak acquisition expanded operations into North Carolina and contributed $37.3M in net patient revenues for the quarter.
Skilled nursing facility census averaged 88.3% for Q3 2024, up from 88.1% a year ago.
Financial highlights
Q3 2024 net operating revenues: $340.2M (Q3 2023: $288.5M); nine months ended September 30, 2024: $938.0M (2023: $840.6M).
Q3 2024 net income attributable to stockholders: $42.8M (Q3 2023: $10.4M); nine months: $95.8M (2023: $38.4M).
Q3 2024 diluted EPS: $2.73 (Q3 2023: $0.68); nine months: $6.15 (2023: $2.50).
Q3 2024 adjusted net income (non-GAAP): $19.9M; nine months: $50.9M.
Q3 2024 net unrealized gains on marketable equity securities: $32.8M; nine months: $56.3M.
Outlook and guidance
Management expects continued growth from the White Oak acquisition and ongoing per diem rate increases.
Short-term liquidity is supported by $84.8M in cash, $164.8M in marketable equity securities, and a $50M line of credit.
Long-term liquidity is expected to be met through operating cash flows and available assets.
Latest events from National HealthCare
- Strong revenue and earnings growth, major acquisition, and new credit facility drive expansion.NHC
Q2 20243 Jul 2026 - Q3 2025 saw strong revenue growth and margin gains, but lease and investment risks remain.NHC
Q3 20253 Jul 2026 - 2024 net income surged 52.6% on 14.5% revenue growth, boosted by the White Oak acquisition.NHC
Q4 20243 Jul 2026 - 2025 revenues grew 16.1% to $1.52B, net income reached $120M, and occupancy improved.NHC
Q4 20253 Jul 2026 - Annual meeting to vote on director re-elections, say-on-pay, and review robust governance and ESG.NHC
Proxy filing3 Jul 2026 - Revenue and earnings surged on acquisition and census gains, with strong liquidity and margin improvement.NHC
Q1 20253 Jul 2026 - Q2 2025 revenues surged 24.7% year-over-year, with adjusted net income up 64.7%.NHC
Q2 20253 Jul 2026 - Q1 2026 net income rose 11% to $35.9M; $560M facility acquisition announced for Q3 close.NHC
Q1 20263 Jul 2026 - 2026 proxy details director elections, say-on-pay, auditor change, and strong ESG focus.NHC
Proxy filing3 Jul 2026